Đang chuẩn bị liên kết để tải về tài liệu:
Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Bevacizumab (Bev) plays the central role of the adjuvant therapy for patients with ovarian carcinoma. The aim of our study was to examine whether differences in the administration of Bev influence the prognosis of patients. |

TÀI LIỆU LIÊN QUAN

AMAZONIAN ACCESSIONS OF WILD HEVEA GERMPLASM - A POTENTIAL SOURCE OF DROUGHT TOLERANCE

In vitro efficacy of native trichoderma isolates against Pythium spp. and Rhizoctonia Solani (Kuhn.) causing damping-off disease in tomato (Solanum lycopersicum Miller)

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma

Potential health risks of exposure to noise from personal music players and mobile phones including a music playing function

Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase

Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electrohyperthermia

Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis

Efficacy of aqueous and methanol extracts of some medicinal plants for potential antibacterial activity
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.